Caspase-4/11 promotes hyperlipidemia and chronic kidney disease–accelerated vascular inflammation by enhancing trained immunity is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.443. It has been cited 13 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.0476
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
NIH
Grant: NIH GRANT TO XY
NIH
Grant: HW
NHLBI NIH HHS
Grant: R01 HL163570
NHLBI NIH HHS
Grant: R01 HL147565
NIDDK NIH HHS
Grant: R01 DK113775
National Institutes of Health
Grant: 5R01DK113775-04
CD40 monocyte in chronic kidney disease
National Institutes of Health
Grant: 1R01HL163570-01A1
LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis
National Institutes of Health
Grant: 1R01HL147565-01
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation
Fields of Study
MeSH Terms
Keywords